UTI Healthcare Fund - Regular Plan - Growth Option

(Erstwhile UTI Pharma & Healthcare Fund-Growth Option)
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 01-08-2005
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 2.55% As on (31-01-2020)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 390.37 Cr As on (29-02-2020)
Turn over: 46% | Exit Load: 1% for redemption within 364 days

76.5369

10.32%

PERFORMANCE

Returns Type:
of  
Start :  
End : 
Period:  
This Scheme
-
vs
S&P BSE Healthcare TRI
-
Gold
-
PPF
-
Returns Type:
of  
  Period:  

Start :  
Period:  

RETURNS ANALYSIS

Fund Multiplier

Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)

Time Taken To Multiply
2x
4x
5x
10x
FUND
0 Years 4 Months
5 Years 2 Months
7 Years 9 Months
9 Years 8 Months
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months

 

Investment Objective

An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.

Current Asset Allocation (%)

Indicators

Volatility 15.99
Sharp Ratio 0.16
Alpha -3.52
Beta 1.04
Yield to Maturity -
Average Maturity -

PEER COMPARISON

Scheme Name Inception
Date
1 Year
Return(%)
2 Year
Return(%)
3 Year
Return(%)
5 Year
Return(%)
10 Year
Return(%)
UTI Healthcare Fund - Regular Plan - Growth Option 01-08-2005 -9.18 -4.11 -4.86 -4.63 8.42
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 1.1 - - - -
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 - - - - -
Mirae Asset Healthcare Fund -Regular Growth 20-07-2018 -2.43 - - - -
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 -3.79 - - - -
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 -4.48 0.26 -1.91 - -
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 14-07-1999 -7.49 -4.24 -7.22 -4.42 11.34
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 -7.61 1.28 0.71 0.43 11.06
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 -8.02 - - - -

Scheme Characteristics

Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.

Riskometer

riskometer

PORTFOLIO

Market Cap Distribution

Small Cap

13.61%

Others

1.86%

Large Cap

46.4%

Mid Cap

38.13%

Tax Benefits of investing in this fund

Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#

Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.

Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **

# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund

Feedback